Xenogen Corporation
Xenogen Corporation is an integrated system of instruments and equipment, software and reagents to academic and biopharmaceutical
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Xenogen Corporation Information
Xenogen Corporation was acquired by
Caliper Life Sciences.
The acquisition happend on 2006-02-13.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Alameda
State: California
Zip:
Country: United States
Financial Info
Stage:
debt financing
Raised Last:
$18M
Raised Total:$115M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Xenogen Corporation is a biotechnology company offering an integrated suite of biophotonic real-time in vivo imaging and genetic modification technologies that can help expedite drug discovery and development, and significantly reduce the cost and time to market for new therapies. Xenogen&s;s VivoVision(TM) Systems non-invasively illuminate and monitor biological processes within living mammals, at the molecular level, in real time. The technology is designed to provide higher quality in vivo data earlier in the drug discovery and development process. VivoVision(TM) Solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. VivoVision(TM) Biosciences represents more than 15 years of experience in the creation and characterization of animal models, including genetic modifications, comprehensive phenotyping, compound profiling and custom design and production of light producing cells, microorganisms and animals.
Contact Phone:
Contact Email:
Xenogen Corporation went public on 7/16/2004 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/16/2004
Ticker Symbol:
XGEN
IPO Price:
$7/share
Amount Raised:
$29M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/1999 | Series D | 4 | $11M |
Charlesbank Capital Partners Delphi Ventures Invemed Associates SR One Charlesbank Capital Partners Delphi Ventures Invemed Associates SR One |
1/2001 | Series G | $25M | 1/1998 | Series C | $8M | 10/2005 | Debt Financing | 2 | $18M |
Partners for Growth Silicon Valley Bank Partners for Growth Silicon Valley Bank |
5/2000 | Series E | 4 | $30.6M |
Charlesbank Capital Partners Delphi Ventures Invemed Associates SR One Charlesbank Capital Partners Delphi Ventures Invemed Associates SR One |
7/2003 | Venture Round | 1 | $22M |
Abingworth Abingworth |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
